The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Faron Pharmaceuticals Ltd - Turku, Finland-based.
The US Food and Drug Administration (FDA) has granted orphan drug designation to Faron Pharmaceuticals’ bexmarilimab to treat acute myeloid leukemia (AML).
The following stocks are the leading risers and fallers on AIM in London on Tuesday.
AIM - WINNERS
Pantheon Resources PLC, up 13% at 15.31p, 12-month range 10.10p-136.00p. The.
Faron Pharmaceuticals Ltd on Wednesday said data from its phase 1 BEXMAB study has shown positive data.
The Finland-based clinical-stage biopharmaceutical company said three of five patients in the.
TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.